Interleukin-6-associated laboratory parameters and immunohistochemistry in symptomatic stage A and B nodular sclerosing Hodgkin's disease in children

Annals of Clinical and Laboratory Science

Volumn 27, Issue 1, 1997, Pages 26-33

  Brown, Robert E ^a   Shah, Narayan R ^a   Lobel, Jeffrey S ^a   George, Bradley A ^a   Gaylord, Harvey ^b   Simonich, William L ^c  

^a GEISINGER MEDICAL CENTER   (United States)

^b R and D Systems Inc   (United States)

^c Amersham Biosciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; ENDOTHELIUM CELL; FEMALE; FEVER; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; MALE; PRIORITY JOURNAL; SCLEROSIS; SMOOTH MUSCLE FIBER; THROMBOCYTOSIS; VASCULAR SMOOTH MUSCLE;

ADOLESCENT; BLOOD PLATELETS; CHILD; DENDRITES; FEMALE; FERRITINS; FEVER; HEMATOCRIT; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; MALE; NEOPLASM STAGING; SERUM ALBUMIN;

EID: 0031024624     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer. Principles & Practice of Oncology, 3rd ed. Philadelphia; J. B. Lippincott Co., 1989:1704.
2. Ferry JA, Linggood RM, Convery KM, et al. Hodgkin disease, nodular sclerosis type. Implications of histologic subclassification. Cancer 1993;71:457-63.
3. Friedman RB, Young DS. Effects of Disease on Clinical Laboratory Tests, 2nd ed, Washington: AACC Press, 1989.
4. Beutler F, Lichtman MA, Coller BS, et al, eds, Williams Hematology, 5th ed. New York: McGraw-Hill, Inc., 1995:163.
5. Asano BS, Okano A, Ozawa K, et al. In vivo effects of recombinant human interleukin-6 in primates: stimulated production of platelets. Blood 1990;75:1602-5.
6. Kobune M, Kohgo Y, Kato J, et al. Interleukin-6 enhances hepatic transferrin uptake and ferritin expression in rats. Hepatology 1994;19:1468-75.
7. Dinarello CA. The endogenous pyrogens in host-defense interactions. Hospital Practice Nov. 15, 1989; 111-28.
8. Meites S, Buffone GJ, Cheng MH, et al, eds. Pediatric Clinical Chemistry. Reference (Normal) Values, 3rd ed. Washington: AACC Press, 1989:37.
9. Nathan DG, Oski FA. Hematology of Infancy and Childhood, 3rd ed, Philadelphia: W. B. Saunders Co., 1987:1680.
10. Lynch S, Brown RE, Laboratory values - the pediatric range. In: Summitt RL, editor. Comprehensive Pediatrics. St. Louis: The C. V. Mosby Co., 1990;1217-36.
11. SAS Institute, Inc: SAS/STAT® User's Guide, Version 6. 4th ed. Cary, NC: SAS Institute, Inc., 1989.
12. Mehta C, Patel N. StatXact 3 for windows: Statistical software for exact nonparametric inference. User Manual. Cambridge, MA: Cytel Software Corporation, 1995.
13. Beck JT, Hsu S-M, Wijdenes J, et al. Brief report: Alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. N Engl J Med 1994;330:602-5.
14. Cause A, Scholz R, Klein S, et al. Increased levels of circulating interleukin-6 in patients with Hodgkin's disease. Hematological Oncol 1991;9:307-13.
15. Kurzrock R, Redman J, Cabanillas F, et al. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms. Cancer Res 1993;53:2118-22.
16. Martich CD, Danner RL, Ceska M, ed al. Detection of interleukin 8 and, tumor necrosis factor in normal humans after intravenous endotoxin: The effect of anti-inflammatory agents. J Exp Med 1001;173: 1021-4.